WELL + GOOD: Here’s how the end of the COVID-19 public health emergency could affect you, according to MDs
UC expert gives background on the policy and who will be most impacted by the end of the emergency
The Biden Administration recently announced that the COVID-19 Public Health Emergency (PHE) and national emergency declarations would be ending on May 11, 2023. The declarations were first announced in early 2020 at the beginning of the COVID-19 pandemic. These declarations have been powerful federal decisions that increase access to emergency funding for public health needs and relax red tape around resource access—but they also served as a strong statement to the American people about the risk of a contagious pandemic.
In a story on the end of the emergency, WELL + GOOD interviewed several experts including Carl Fichtenbaum, MD, of the Division of Infectious Diseases in the Department of Internal Medicine at the UC College of Medicine.
"The policy was developed in response to the COVID pandemic to be able to issue orders, procure drugs/vaccines, and coordinate agency responses," said Fichtenbaum. "More than anything, it provided a vehicle to implement funding measures enacted by Congress and the President."
Some of the biggest impacts this end of the PHE will have on public health will affect the most vulnerable among us, such as immunocompromised individuals, older adults, and children. That number grows if you consider the number of people experiencing long-term COVID complications.
"This will affect citizens who previously had received free testing, it will cost money or you’ll have to use your insurance to test for COVID-19 and vaccinations will now be billed to insurance so that access may be limited for those without insurance," Fichtenbaum told WELL + GOOD. "Subsidies given to companies to produce vaccine and drugs will begin to fade away. And the agencies that retooled to deal with the COVID pandemic will have to go back to regular operations."
Lead image/Getty Images/Westend61
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
2021 University Recognition Ceremony honors student achievements
April 13, 2021
The University of Cincinnati recognizes students each year who have made significant service, leadership, and academic contributions to the UC community. These students exemplify the spirit of what it means to be a Bearcat.
UC Day of Giving a success
April 28, 2021
University of Cincinnati Day of Giving’s 24-hour challenge was a tremendous success this year, raising $2,219,197 with 3,232 gifts. The fourth annual UC Day of Giving raised its most money to date with alumni, donors, students, faculty and staff joining together to support UC and UC Health.
President picks exceptional talent
April 28, 2021
The University of Cincinnati 2021 Presidential Leadership Medal of Excellence Awards honor six undergraduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.
Grad students earn president's highest honor
April 28, 2021
The University of Cincinnati 2021 Presidential Medal of Graduate Student Excellence Awards honor three graduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.
GIVEHOPE and BSI Engineering Celebrate Ten Years of Driving Research
August 3, 2021
Years after two personal losses from pancreatic cancer, Cincinnati-based nonprofit GIVEHOPE and consulting firm BSI Engineering are celebrating a philanthropic partnership that has funded 13 pilot research projects at the University of Cincinnati Cancer Center.
Finding community and building a future
July 9, 2021
As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”
New York Times: Flint Weighs Scope of Harm to Children Caused by Lead in Water
February 1, 2016
Kim Dietrich, a professor of environmental health at UC's College of Medicine, is quoted in this story on the medical problems that could develop among the thousands of young children exposed to lead-contaminated water in Flint, Mich.
Cancer-Causing Gene Found in Plasma May Help Predict Outcomes for Patients
February 18, 2016
Researchers at the University of Cincinnati have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients.
UC Receives $1.9 Million to Study Pain
February 15, 2016
Jun-Ming Zhang, MD, of the UC College of Medicine, is the principal investigator of a $1.95 million grant to study the interacting roles of the sympathetic and sensory nervous and immune systems in back and neuropathic pain models.
MD Magazine: Generic Drug Equally Effective in Epilespy
February 22, 2016
Michael Privitera, MD, a professor of neurology at UC's College of Medicine and director of the Epilepsy Center at the UC Neuroscience Institute, is featured in this story about research he led that examined the efficacy of generic drug substitution for epilepsy.